Trevi Therapeutics, Inc.TRVINASDAQ
Loading
Operating Income ContractionContracting
Percentile Rank11
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

Latest
$-49.33M
↓ 69% vs avg
Percentile
P11
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-29.16M
Historical baseline
PeriodValueYoY Change
TTM$-49.33M+4.3%
2024$-51.52M-51.9%
2023$-33.92M-13.4%
2022$-29.91M+7.9%
2021$-32.48M+0.0%
2020$-32.49M-21.9%
2019$-26.64M-44.7%
2018$-18.41M-123.5%
2017$-8.24M+4.5%
2016$-8.63M-